The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
Purpose
The goal of this pilot study is to explore a combination of two interventions: (1) a behavioral alcohol-reduction intervention using motivational interviewing, and (2) a blinded probiotic microbiome or placebo intervention. The study examines whether these interventions improve cognitive and neurophysiological function, including brain metabolism, in older adults who are high-risk alcohol drinkers.
Conditions
- Aging
- Alcohol Drinking
Eligibility
- Eligible Ages
- Between 65 Years and 84 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Between 65 and 84 years of age - English speaking - Able to provide valid informed consent, understand requirement and risk/benefits of the study and comply with study protocol - Heavy drinker defined as >14 alcoholic drinks/week for men and >7 drinks/week for women - Interested in reducing their alcohol consumption
Exclusion Criteria
- BMI ≥ 35 - Fasting Glucose > 125 mg/dL - Current or previously diagnosed with Type 1 or 2 Diabetes - Requires the use of insulin and/or other glucose lowering agents - Unable to fast for 12 hours - Past serious alcohol withdrawal symptoms - MRI Contraindications (e.g., certain devices and implants, claustrophobic) - Diagnosed with a neurodegenerative disease (e.g., Alzheimer's Disease) - Diagnosed with a psychotic disorder - Current substance dependence diagnosis (except for mild or moderate alcohol) - Consumption of over 300 drinks in the past 30 days - Current probiotic use or recent probiotic use within the past 30 days - Current antibiotic use or recent antibiotic use within the past 30 days - In active cancer treatment and/or have advanced cancer - Taking daily steroids and/or immunosuppressants - Lifetime organ or bone marrow transplant; primary immunodeficiency (e.g., DiGeorge syndrome or Wiskott-Aldrich syndrome) or transplant recipient or prescribed immunosuppressant medications - PI's discretion
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Basic Science
- Masking
- Double (Participant, Investigator)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Experimental Motivational Interviewing + Probiotic |
Participants in this arm will be given a brief motivational interview to promote drinking reduction. During the 30-day intervention, participants will receive an active probiotic supplement 900 billion colony forming units (CFU), once daily. |
|
|
Placebo Comparator Motivational Interviewing + Placebo |
Participants in this arm will be given a brief motivational interview to promote drinking reduction. During the 30-day intervention, participants will receive a placebo supplement once daily. |
|
Recruiting Locations
University of Miami
Miami, Florida 33136
Miami, Florida 33136
More Details
- Status
- Recruiting
- Sponsor
- University of Miami